Search Within

Thoracic Oncology

  1. "Christopher Azzoli"
Formats
  1. Journal Article (46)
  2. Meeting Abstract (37)
Groups
  1. Department of Medicine (83)
  2. Solid Tumor Oncology Division (83)
  3. Survivorship Research (31)
  4. Surgery (26)
  5. Nursing (23)
  6. Radiology, Department of (23)

More Groups

People
  1. Christopher Azzoli (83)
  2. Mark Kris (83)
  3. Vincent Miller (45)
  4. Lee Krug (37)
  5. Naiyer Rizvi (37)
  6. Gregory Riely (28)

More People

Years
  1. 2014 (2)
  2. 2013 (5)
  3. 2012 (8)
  4. 2011 (12)
  5. 2010 (7)
  6. 2009 (7)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Journal of Thoracic Oncology (20)
  3. Clinical Cancer Research (8)
  4. Cancer Chemotherapy and Pharmacology (7)
  5. Cancer (4)
  6. Lung Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Elsevier Inc. (23)
  3. American Association for Cancer Research (9)
  4. Springer (8)
  5. Wiley Blackwell (4)
  6. Elsevier Ireland Ltd. (3)

More Publishers

Results (83)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC
    Meeting Abstract

    Pennell, N. A.; Neal, J. W.; Chaft, J. E.; Azzoli, C. G.; Jänne, P. A.; Govindan, R.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Wakelee, H. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation
    Journal Article

    Chaft, J. E.; Litvak, A.; Arcila, M. E.; Patel, P.; D'Angelo, S. P.; Krug, L. M.; Rusch, V.; Mattson, A.; Coeshott, C.; Park, B.; more...
    Clinical Lung Cancer (2014)

    Fulltext@MSK | Save
  • A phase II trial of paclitaxel, pemetrexed and bevacizumab in patients with untreated, advanced lung cancers
    Meeting Abstract

    Pietanza, M. C.; Hellmann, M. D.; Rizvi, N.; Azzoli, C. G.; Smith-Marrone, S.; Fiore, J.; Tyson, L. B.; Sumner, D. K.; Hergianto, A. B.; Kass, S. L.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers
    Journal Article

    Chaft, J. E.; Rekhtman, N.; Sima, C. S.; Rusch, V.; Kris, M. G.; Zakowski, M.; Azzoli, C. G.
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
    Journal Article

    Hellmann, M. D.; Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers
    Journal Article

    Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Journal Article

    Yu, H. A.; Sima, C. S.; Huang, J.; Solomon, S. B.; Rimner, A.; Paik, P.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Drilon, A. E. D.; Varghese, A. M.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; Kris, M. G.; Miller, V. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Quantitating pathologic response to neoadjuvant chemotherapy in KRAS-mutated versus nonmutated lung cancers
    Meeting Abstract

    Chaft, J. E.; Paik, P. K.; Sima, C. S.; Kris, M. G.; Krug, L. M.; Azzoli, C. G.; Riely, G. J.; Pietanza, M. C.; Rusch, V. W.; Travis, W. D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save